nodes	percent_of_prediction	percent_of_DWPC	metapath
Naloxone—SLCO1A2—epilepsy syndrome	0.142	0.354	CbGaD
Naloxone—OPRD1—epilepsy syndrome	0.118	0.294	CbGaD
Naloxone—OPRM1—epilepsy syndrome	0.0904	0.225	CbGaD
Naloxone—ALB—epilepsy syndrome	0.0262	0.0652	CbGaD
Naloxone—ABCB1—epilepsy syndrome	0.025	0.0622	CbGaD
Naloxone—ALB—Oxcarbazepine—epilepsy syndrome	0.0221	0.0649	CbGbCtD
Naloxone—ALB—Fosphenytoin—epilepsy syndrome	0.0193	0.0568	CbGbCtD
Naloxone—ALB—Clonazepam—epilepsy syndrome	0.0175	0.0513	CbGbCtD
Naloxone—CYP2C8—Trimethadione—epilepsy syndrome	0.0159	0.0466	CbGbCtD
Naloxone—CYP2C8—Fosphenytoin—epilepsy syndrome	0.0149	0.0439	CbGbCtD
Naloxone—ALB—Rufinamide—epilepsy syndrome	0.0142	0.0418	CbGbCtD
Naloxone—ABCB1—Levetiracetam—epilepsy syndrome	0.0126	0.0371	CbGbCtD
Naloxone—ALB—Phenytoin—epilepsy syndrome	0.0124	0.0366	CbGbCtD
Naloxone—ALB—Propofol—epilepsy syndrome	0.0116	0.0341	CbGbCtD
Naloxone—CYP2C8—Carbamazepine—epilepsy syndrome	0.0107	0.0315	CbGbCtD
Naloxone—ALB—Diazepam—epilepsy syndrome	0.0105	0.0309	CbGbCtD
Naloxone—CYP2C8—Primidone—epilepsy syndrome	0.01	0.0294	CbGbCtD
Naloxone—CYP2C8—Phenytoin—epilepsy syndrome	0.00961	0.0283	CbGbCtD
Naloxone—CYP2C8—Propofol—epilepsy syndrome	0.00896	0.0264	CbGbCtD
Naloxone—ABCB1—Clobazam—epilepsy syndrome	0.00875	0.0257	CbGbCtD
Naloxone—CYP2C8—Phenobarbital—epilepsy syndrome	0.00856	0.0252	CbGbCtD
Naloxone—ABCB1—Lamotrigine—epilepsy syndrome	0.00842	0.0248	CbGbCtD
Naloxone—CYP2C8—Diazepam—epilepsy syndrome	0.00812	0.0239	CbGbCtD
Naloxone—ABCB1—Carbamazepine—epilepsy syndrome	0.00725	0.0213	CbGbCtD
Naloxone—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00692	0.0203	CbGbCtD
Naloxone—ABCB1—Phenytoin—epilepsy syndrome	0.0065	0.0191	CbGbCtD
Naloxone—CYP3A4—Felbamate—epilepsy syndrome	0.00643	0.0189	CbGbCtD
Naloxone—CYP3A4—Trimethadione—epilepsy syndrome	0.00643	0.0189	CbGbCtD
Naloxone—CYP2C8—Valproic Acid—epilepsy syndrome	0.0064	0.0188	CbGbCtD
Naloxone—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00605	0.0178	CbGbCtD
Naloxone—ABCB1—Phenobarbital—epilepsy syndrome	0.0058	0.0171	CbGbCtD
Naloxone—ABCB1—Midazolam—epilepsy syndrome	0.00572	0.0168	CbGbCtD
Naloxone—ABCB1—Diazepam—epilepsy syndrome	0.0055	0.0162	CbGbCtD
Naloxone—CYP3A4—Clonazepam—epilepsy syndrome	0.00547	0.0161	CbGbCtD
Naloxone—CYP3A4—Clobazam—epilepsy syndrome	0.00524	0.0154	CbGbCtD
Naloxone—CYP3A4—Rufinamide—epilepsy syndrome	0.00446	0.0131	CbGbCtD
Naloxone—CYP3A4—Carbamazepine—epilepsy syndrome	0.00434	0.0128	CbGbCtD
Naloxone—CYP3A4—Primidone—epilepsy syndrome	0.00406	0.0119	CbGbCtD
Naloxone—CYP3A4—Phenytoin—epilepsy syndrome	0.0039	0.0115	CbGbCtD
Naloxone—CYP3A4—Propofol—epilepsy syndrome	0.00363	0.0107	CbGbCtD
Naloxone—CREB1—telencephalic ventricle—epilepsy syndrome	0.00358	0.0966	CbGeAlD
Naloxone—CYP3A4—Phenobarbital—epilepsy syndrome	0.00347	0.0102	CbGbCtD
Naloxone—CYP3A4—Acetazolamide—epilepsy syndrome	0.00347	0.0102	CbGbCtD
Naloxone—CYP3A4—Midazolam—epilepsy syndrome	0.00343	0.0101	CbGbCtD
Naloxone—CYP3A4—Diazepam—epilepsy syndrome	0.00329	0.00968	CbGbCtD
Naloxone—CYP3A4—Zonisamide—epilepsy syndrome	0.00321	0.00945	CbGbCtD
Naloxone—CYP3A4—Valproic Acid—epilepsy syndrome	0.0026	0.00763	CbGbCtD
Naloxone—CYP3A4—Topiramate—epilepsy syndrome	0.00234	0.00689	CbGbCtD
Naloxone—CREB1—ganglion—epilepsy syndrome	0.00223	0.0602	CbGeAlD
Naloxone—OPRM1—telencephalic ventricle—epilepsy syndrome	0.00193	0.0521	CbGeAlD
Naloxone—OPRD1—ganglion—epilepsy syndrome	0.00176	0.0475	CbGeAlD
Naloxone—CREB1—hindbrain—epilepsy syndrome	0.00169	0.0456	CbGeAlD
Naloxone—OPRM1—ganglion—epilepsy syndrome	0.0012	0.0324	CbGeAlD
Naloxone—TLR4—cerebellum—epilepsy syndrome	0.00109	0.0293	CbGeAlD
Naloxone—CREB1—brainstem—epilepsy syndrome	0.000969	0.0261	CbGeAlD
Naloxone—CREB1—forebrain—epilepsy syndrome	0.000935	0.0252	CbGeAlD
Naloxone—TLR4—brain—epilepsy syndrome	0.000882	0.0238	CbGeAlD
Naloxone—CREB1—telencephalon—epilepsy syndrome	0.00086	0.0232	CbGeAlD
Naloxone—OPRD1—forebrain—epilepsy syndrome	0.000739	0.0199	CbGeAlD
Naloxone—OPRK1—forebrain—epilepsy syndrome	0.000709	0.0191	CbGeAlD
Naloxone—OPRD1—telencephalon—epilepsy syndrome	0.00068	0.0183	CbGeAlD
Naloxone—CREB1—medulla oblongata—epilepsy syndrome	0.000676	0.0182	CbGeAlD
Naloxone—ESR1—hindbrain—epilepsy syndrome	0.000666	0.018	CbGeAlD
Naloxone—CREB1—midbrain—epilepsy syndrome	0.000618	0.0167	CbGeAlD
Naloxone—CREB1—spinal cord—epilepsy syndrome	0.000603	0.0163	CbGeAlD
Naloxone—CREB1—head—epilepsy syndrome	0.000536	0.0144	CbGeAlD
Naloxone—OPRM1—brainstem—epilepsy syndrome	0.000522	0.0141	CbGeAlD
Naloxone—CREB1—nervous system—epilepsy syndrome	0.000508	0.0137	CbGeAlD
Naloxone—OPRM1—forebrain—epilepsy syndrome	0.000504	0.0136	CbGeAlD
Naloxone—CREB1—central nervous system—epilepsy syndrome	0.000489	0.0132	CbGeAlD
Naloxone—CREB1—cerebellum—epilepsy syndrome	0.000478	0.0129	CbGeAlD
Naloxone—OPRM1—telencephalon—epilepsy syndrome	0.000464	0.0125	CbGeAlD
Naloxone—SLCO1A2—forebrain—epilepsy syndrome	0.000434	0.0117	CbGeAlD
Naloxone—OPRD1—head—epilepsy syndrome	0.000423	0.0114	CbGeAlD
Naloxone—OPRK1—head—epilepsy syndrome	0.000406	0.011	CbGeAlD
Naloxone—OPRD1—nervous system—epilepsy syndrome	0.000401	0.0108	CbGeAlD
Naloxone—SLCO1A2—telencephalon—epilepsy syndrome	0.000399	0.0108	CbGeAlD
Naloxone—CREB1—brain—epilepsy syndrome	0.000388	0.0105	CbGeAlD
Naloxone—OPRD1—central nervous system—epilepsy syndrome	0.000386	0.0104	CbGeAlD
Naloxone—Levallorphan—OPRM1—epilepsy syndrome	0.000386	0.0988	CrCbGaD
Naloxone—OPRK1—nervous system—epilepsy syndrome	0.000385	0.0104	CbGeAlD
Naloxone—ESR1—brainstem—epilepsy syndrome	0.000381	0.0103	CbGeAlD
Naloxone—OPRK1—central nervous system—epilepsy syndrome	0.00037	0.01	CbGeAlD
Naloxone—ESR1—forebrain—epilepsy syndrome	0.000368	0.00993	CbGeAlD
Naloxone—OPRK1—cerebellum—epilepsy syndrome	0.000362	0.00977	CbGeAlD
Naloxone—ESR1—telencephalon—epilepsy syndrome	0.000339	0.00913	CbGeAlD
Naloxone—OPRM1—midbrain—epilepsy syndrome	0.000333	0.00898	CbGeAlD
Naloxone—OPRM1—spinal cord—epilepsy syndrome	0.000325	0.00876	CbGeAlD
Naloxone—SLCO1A2—medulla oblongata—epilepsy syndrome	0.000314	0.00846	CbGeAlD
Naloxone—OPRD1—brain—epilepsy syndrome	0.000307	0.00828	CbGeAlD
Naloxone—OPRK1—brain—epilepsy syndrome	0.000294	0.00794	CbGeAlD
Naloxone—OPRM1—head—epilepsy syndrome	0.000289	0.00779	CbGeAlD
Naloxone—SLCO1A2—midbrain—epilepsy syndrome	0.000287	0.00773	CbGeAlD
Naloxone—SLCO1A2—spinal cord—epilepsy syndrome	0.00028	0.00755	CbGeAlD
Naloxone—OPRM1—nervous system—epilepsy syndrome	0.000274	0.00739	CbGeAlD
Naloxone—Nalbuphine—OPRD1—epilepsy syndrome	0.000265	0.0678	CrCbGaD
Naloxone—OPRM1—central nervous system—epilepsy syndrome	0.000264	0.00711	CbGeAlD
Naloxone—SLCO1A2—head—epilepsy syndrome	0.000249	0.00671	CbGeAlD
Naloxone—SLCO1A2—nervous system—epilepsy syndrome	0.000236	0.00636	CbGeAlD
Naloxone—SLCO1A2—central nervous system—epilepsy syndrome	0.000227	0.00612	CbGeAlD
Naloxone—SLCO1A2—cerebellum—epilepsy syndrome	0.000222	0.00598	CbGeAlD
Naloxone—Methylnaltrexone—OPRM1—epilepsy syndrome	0.000221	0.0567	CrCbGaD
Naloxone—Naltrexone—OPRD1—epilepsy syndrome	0.000216	0.0553	CrCbGaD
Naloxone—Oxymorphone—OPRD1—epilepsy syndrome	0.000216	0.0553	CrCbGaD
Naloxone—ESR1—head—epilepsy syndrome	0.000211	0.00569	CbGeAlD
Naloxone—OPRM1—brain—epilepsy syndrome	0.000209	0.00564	CbGeAlD
Naloxone—Nalbuphine—OPRM1—epilepsy syndrome	0.000203	0.0519	CrCbGaD
Naloxone—ESR1—nervous system—epilepsy syndrome	0.0002	0.00539	CbGeAlD
Naloxone—ESR1—central nervous system—epilepsy syndrome	0.000192	0.00519	CbGeAlD
Naloxone—Hydrocodone—OPRD1—epilepsy syndrome	0.000189	0.0483	CrCbGaD
Naloxone—ESR1—cerebellum—epilepsy syndrome	0.000188	0.00507	CbGeAlD
Naloxone—SLCO1A2—brain—epilepsy syndrome	0.00018	0.00486	CbGeAlD
Naloxone—ALB—brain—epilepsy syndrome	0.000179	0.00483	CbGeAlD
Naloxone—Oxycodone—OPRD1—epilepsy syndrome	0.000172	0.0441	CrCbGaD
Naloxone—Naltrexone—OPRM1—epilepsy syndrome	0.000165	0.0423	CrCbGaD
Naloxone—Oxymorphone—OPRM1—epilepsy syndrome	0.000165	0.0423	CrCbGaD
Naloxone—Buprenorphine—OPRD1—epilepsy syndrome	0.000159	0.0406	CrCbGaD
Naloxone—Hydromorphone—OPRD1—epilepsy syndrome	0.000156	0.04	CrCbGaD
Naloxone—ESR1—brain—epilepsy syndrome	0.000153	0.00412	CbGeAlD
Naloxone—ABCB1—forebrain—epilepsy syndrome	0.000145	0.00392	CbGeAlD
Naloxone—Hydrocodone—OPRM1—epilepsy syndrome	0.000144	0.037	CrCbGaD
Naloxone—ABCB1—telencephalon—epilepsy syndrome	0.000134	0.00361	CbGeAlD
Naloxone—Morphine—OPRD1—epilepsy syndrome	0.000133	0.034	CrCbGaD
Naloxone—Oxycodone—OPRM1—epilepsy syndrome	0.000132	0.0337	CrCbGaD
Naloxone—CYP2C8—brain—epilepsy syndrome	0.000126	0.0034	CbGeAlD
Naloxone—Buprenorphine—OPRM1—epilepsy syndrome	0.000121	0.0311	CrCbGaD
Naloxone—Hydromorphone—OPRM1—epilepsy syndrome	0.00012	0.0306	CrCbGaD
Naloxone—Diarrhoea—Clobazam—epilepsy syndrome	0.000115	0.00101	CcSEcCtD
Naloxone—Pain—Levetiracetam—epilepsy syndrome	0.000115	0.00101	CcSEcCtD
Naloxone—Skin disorder—Zonisamide—epilepsy syndrome	0.000114	0.001	CcSEcCtD
Naloxone—Convulsion—Carbamazepine—epilepsy syndrome	0.000114	0.001	CcSEcCtD
Naloxone—Hyperhidrosis—Zonisamide—epilepsy syndrome	0.000114	0.000998	CcSEcCtD
Naloxone—Hypertension—Carbamazepine—epilepsy syndrome	0.000114	0.000998	CcSEcCtD
Naloxone—Paraesthesia—Vigabatrin—epilepsy syndrome	0.000113	0.000994	CcSEcCtD
Naloxone—Sweating—Pregabalin—epilepsy syndrome	0.000112	0.000985	CcSEcCtD
Naloxone—Irritability—Topiramate—epilepsy syndrome	0.000112	0.000981	CcSEcCtD
Naloxone—CYP3A4—nervous system—epilepsy syndrome	0.000112	0.00301	CbGeAlD
Naloxone—Paraesthesia—Diazepam—epilepsy syndrome	0.000111	0.000979	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Carbamazepine—epilepsy syndrome	0.000111	0.000977	CcSEcCtD
Naloxone—Nausea—Phenobarbital—epilepsy syndrome	0.000111	0.000977	CcSEcCtD
Naloxone—Nervous system disorder—Clonazepam—epilepsy syndrome	0.000111	0.000976	CcSEcCtD
Naloxone—Dyspnoea—Diazepam—epilepsy syndrome	0.000111	0.000972	CcSEcCtD
Naloxone—Tachycardia—Clonazepam—epilepsy syndrome	0.000111	0.000971	CcSEcCtD
Naloxone—Nervous system disorder—Phenytoin—epilepsy syndrome	0.00011	0.000969	CcSEcCtD
Naloxone—Convulsion—Lamotrigine—epilepsy syndrome	0.00011	0.000968	CcSEcCtD
Naloxone—Skin disorder—Clonazepam—epilepsy syndrome	0.00011	0.000967	CcSEcCtD
Naloxone—Tachycardia—Phenytoin—epilepsy syndrome	0.00011	0.000965	CcSEcCtD
Naloxone—Hypertension—Lamotrigine—epilepsy syndrome	0.00011	0.000965	CcSEcCtD
Naloxone—Nervous system disorder—Oxcarbazepine—epilepsy syndrome	0.00011	0.000964	CcSEcCtD
Naloxone—Vomiting—Lacosamide—epilepsy syndrome	0.00011	0.000964	CcSEcCtD
Naloxone—Abdominal pain—Propofol—epilepsy syndrome	0.00011	0.000963	CcSEcCtD
Naloxone—Body temperature increased—Propofol—epilepsy syndrome	0.00011	0.000963	CcSEcCtD
Naloxone—Tachycardia—Oxcarbazepine—epilepsy syndrome	0.000109	0.00096	CcSEcCtD
Naloxone—Nausea—Rufinamide—epilepsy syndrome	0.000109	0.000959	CcSEcCtD
Naloxone—Gastrointestinal disorder—Vigabatrin—epilepsy syndrome	0.000109	0.000956	CcSEcCtD
Naloxone—Hyperhidrosis—Phenytoin—epilepsy syndrome	0.000109	0.000956	CcSEcCtD
Naloxone—Skin disorder—Oxcarbazepine—epilepsy syndrome	0.000109	0.000955	CcSEcCtD
Naloxone—Hyperhidrosis—Oxcarbazepine—epilepsy syndrome	0.000108	0.000951	CcSEcCtD
Naloxone—Paraesthesia—Felbamate—epilepsy syndrome	0.000108	0.000947	CcSEcCtD
Naloxone—Pain—Vigabatrin—epilepsy syndrome	0.000108	0.000947	CcSEcCtD
Naloxone—CYP3A4—central nervous system—epilepsy syndrome	0.000107	0.0029	CbGeAlD
Naloxone—Gastrointestinal disorder—Diazepam—epilepsy syndrome	0.000107	0.000941	CcSEcCtD
Naloxone—Asthenia—Acetazolamide—epilepsy syndrome	0.000107	0.000941	CcSEcCtD
Naloxone—Dyspnoea—Felbamate—epilepsy syndrome	0.000107	0.00094	CcSEcCtD
Naloxone—Depression—Gabapentin—epilepsy syndrome	0.000107	0.000939	CcSEcCtD
Naloxone—Vomiting—Clobazam—epilepsy syndrome	0.000107	0.000935	CcSEcCtD
Naloxone—Pain—Diazepam—epilepsy syndrome	0.000106	0.000932	CcSEcCtD
Naloxone—Body temperature increased—Levetiracetam—epilepsy syndrome	0.000106	0.00093	CcSEcCtD
Naloxone—Abdominal pain—Levetiracetam—epilepsy syndrome	0.000106	0.00093	CcSEcCtD
Naloxone—Paraesthesia—Zonisamide—epilepsy syndrome	0.000106	0.000927	CcSEcCtD
Naloxone—Angiopathy—Valproic Acid—epilepsy syndrome	0.000105	0.000925	CcSEcCtD
Naloxone—Nervous system disorder—Carbamazepine—epilepsy syndrome	0.000105	0.000925	CcSEcCtD
Naloxone—ABCB1—medulla oblongata—epilepsy syndrome	0.000105	0.00283	CbGeAlD
Naloxone—Tachycardia—Carbamazepine—epilepsy syndrome	0.000105	0.000921	CcSEcCtD
Naloxone—Dyspnoea—Zonisamide—epilepsy syndrome	0.000105	0.000921	CcSEcCtD
Naloxone—Nasopharyngitis—Topiramate—epilepsy syndrome	0.000105	0.000919	CcSEcCtD
Naloxone—Mediastinal disorder—Valproic Acid—epilepsy syndrome	0.000105	0.000919	CcSEcCtD
Naloxone—Hallucination—Pregabalin—epilepsy syndrome	0.000105	0.000917	CcSEcCtD
Naloxone—Skin disorder—Carbamazepine—epilepsy syndrome	0.000104	0.000916	CcSEcCtD
Naloxone—Chills—Valproic Acid—epilepsy syndrome	0.000104	0.000915	CcSEcCtD
Naloxone—Hyperhidrosis—Carbamazepine—epilepsy syndrome	0.000104	0.000912	CcSEcCtD
Naloxone—Sweating—Gabapentin—epilepsy syndrome	0.000103	0.000903	CcSEcCtD
Naloxone—Pain—Felbamate—epilepsy syndrome	0.000103	0.000902	CcSEcCtD
Naloxone—Nausea—Lacosamide—epilepsy syndrome	0.000103	0.0009	CcSEcCtD
Naloxone—Body temperature increased—Fosphenytoin—epilepsy syndrome	0.000102	0.000898	CcSEcCtD
Naloxone—Diarrhoea—Acetazolamide—epilepsy syndrome	0.000102	0.000897	CcSEcCtD
Naloxone—Nervous system disorder—Lamotrigine—epilepsy syndrome	0.000102	0.000894	CcSEcCtD
Naloxone—Mental disorder—Valproic Acid—epilepsy syndrome	0.000102	0.000894	CcSEcCtD
Naloxone—Morphine—OPRM1—epilepsy syndrome	0.000102	0.0261	CrCbGaD
Naloxone—Gastrointestinal disorder—Zonisamide—epilepsy syndrome	0.000102	0.000891	CcSEcCtD
Naloxone—Tachycardia—Lamotrigine—epilepsy syndrome	0.000101	0.00089	CcSEcCtD
Naloxone—Paraesthesia—Phenytoin—epilepsy syndrome	0.000101	0.000888	CcSEcCtD
Naloxone—Dyspnoea—Clonazepam—epilepsy syndrome	0.000101	0.000887	CcSEcCtD
Naloxone—Hyperhidrosis—Lamotrigine—epilepsy syndrome	0.0001	0.000882	CcSEcCtD
Naloxone—Dyspnoea—Phenytoin—epilepsy syndrome	0.0001	0.000881	CcSEcCtD
Naloxone—Dyspnoea—Oxcarbazepine—epilepsy syndrome	9.99e-05	0.000877	CcSEcCtD
Naloxone—Body temperature increased—Vigabatrin—epilepsy syndrome	9.97e-05	0.000875	CcSEcCtD
Naloxone—Abdominal pain—Vigabatrin—epilepsy syndrome	9.97e-05	0.000875	CcSEcCtD
Naloxone—Nausea—Clobazam—epilepsy syndrome	9.96e-05	0.000874	CcSEcCtD
Naloxone—Asthenia—Propofol—epilepsy syndrome	9.96e-05	0.000874	CcSEcCtD
Naloxone—Tension—Valproic Acid—epilepsy syndrome	9.93e-05	0.000871	CcSEcCtD
Naloxone—Nervousness—Valproic Acid—epilepsy syndrome	9.82e-05	0.000862	CcSEcCtD
Naloxone—Abdominal pain—Diazepam—epilepsy syndrome	9.82e-05	0.000862	CcSEcCtD
Naloxone—Gastrointestinal disorder—Clonazepam—epilepsy syndrome	9.79e-05	0.000859	CcSEcCtD
Naloxone—Flushing—Pregabalin—epilepsy syndrome	9.75e-05	0.000856	CcSEcCtD
Naloxone—Cardiac disorder—Pregabalin—epilepsy syndrome	9.75e-05	0.000856	CcSEcCtD
Naloxone—Asthenia—Midazolam—epilepsy syndrome	9.74e-05	0.000855	CcSEcCtD
Naloxone—Gastrointestinal disorder—Phenytoin—epilepsy syndrome	9.72e-05	0.000853	CcSEcCtD
Naloxone—Pain—Clonazepam—epilepsy syndrome	9.69e-05	0.000851	CcSEcCtD
Naloxone—Gastrointestinal disorder—Oxcarbazepine—epilepsy syndrome	9.67e-05	0.000849	CcSEcCtD
Naloxone—Paraesthesia—Carbamazepine—epilepsy syndrome	9.65e-05	0.000847	CcSEcCtD
Naloxone—Asthenia—Levetiracetam—epilepsy syndrome	9.62e-05	0.000844	CcSEcCtD
Naloxone—ABCB1—midbrain—epilepsy syndrome	9.6e-05	0.00259	CbGeAlD
Naloxone—Hallucination—Gabapentin—epilepsy syndrome	9.58e-05	0.000841	CcSEcCtD
Naloxone—Dyspnoea—Carbamazepine—epilepsy syndrome	9.58e-05	0.000841	CcSEcCtD
Naloxone—Pain—Oxcarbazepine—epilepsy syndrome	9.58e-05	0.000841	CcSEcCtD
Naloxone—Angiopathy—Pregabalin—epilepsy syndrome	9.53e-05	0.000837	CcSEcCtD
Naloxone—Body temperature increased—Felbamate—epilepsy syndrome	9.5e-05	0.000834	CcSEcCtD
Naloxone—Abdominal pain—Felbamate—epilepsy syndrome	9.5e-05	0.000834	CcSEcCtD
Naloxone—Vomiting—Acetazolamide—epilepsy syndrome	9.5e-05	0.000834	CcSEcCtD
Naloxone—Diarrhoea—Propofol—epilepsy syndrome	9.49e-05	0.000833	CcSEcCtD
Naloxone—Tremor—Valproic Acid—epilepsy syndrome	9.48e-05	0.000832	CcSEcCtD
Naloxone—Mediastinal disorder—Pregabalin—epilepsy syndrome	9.47e-05	0.000831	CcSEcCtD
Naloxone—Chills—Pregabalin—epilepsy syndrome	9.43e-05	0.000827	CcSEcCtD
Naloxone—ABCB1—spinal cord—epilepsy syndrome	9.37e-05	0.00253	CbGeAlD
Naloxone—Paraesthesia—Lamotrigine—epilepsy syndrome	9.33e-05	0.000819	CcSEcCtD
Naloxone—Body temperature increased—Zonisamide—epilepsy syndrome	9.3e-05	0.000816	CcSEcCtD
Naloxone—Abdominal pain—Zonisamide—epilepsy syndrome	9.3e-05	0.000816	CcSEcCtD
Naloxone—Agitation—Valproic Acid—epilepsy syndrome	9.29e-05	0.000816	CcSEcCtD
Naloxone—Asthenia—Fosphenytoin—epilepsy syndrome	9.28e-05	0.000815	CcSEcCtD
Naloxone—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	9.28e-05	0.000815	CcSEcCtD
Naloxone—Dyspnoea—Lamotrigine—epilepsy syndrome	9.26e-05	0.000813	CcSEcCtD
Naloxone—Mental disorder—Pregabalin—epilepsy syndrome	9.2e-05	0.000808	CcSEcCtD
Naloxone—Pain—Carbamazepine—epilepsy syndrome	9.19e-05	0.000807	CcSEcCtD
Naloxone—Diarrhoea—Levetiracetam—epilepsy syndrome	9.17e-05	0.000805	CcSEcCtD
Naloxone—Asthenia—Vigabatrin—epilepsy syndrome	9.05e-05	0.000794	CcSEcCtD
Naloxone—Depression—Topiramate—epilepsy syndrome	9e-05	0.00079	CcSEcCtD
Naloxone—Tension—Pregabalin—epilepsy syndrome	8.97e-05	0.000788	CcSEcCtD
Naloxone—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	8.97e-05	0.000787	CcSEcCtD
Naloxone—Body temperature increased—Clonazepam—epilepsy syndrome	8.96e-05	0.000787	CcSEcCtD
Naloxone—Abdominal pain—Clonazepam—epilepsy syndrome	8.96e-05	0.000787	CcSEcCtD
Naloxone—Cardiac disorder—Gabapentin—epilepsy syndrome	8.94e-05	0.000785	CcSEcCtD
Naloxone—Asthenia—Diazepam—epilepsy syndrome	8.91e-05	0.000782	CcSEcCtD
Naloxone—Body temperature increased—Phenytoin—epilepsy syndrome	8.9e-05	0.000781	CcSEcCtD
Naloxone—Pain—Lamotrigine—epilepsy syndrome	8.88e-05	0.00078	CcSEcCtD
Naloxone—Nervousness—Pregabalin—epilepsy syndrome	8.88e-05	0.00078	CcSEcCtD
Naloxone—Nausea—Acetazolamide—epilepsy syndrome	8.87e-05	0.000779	CcSEcCtD
Naloxone—Abdominal pain—Oxcarbazepine—epilepsy syndrome	8.85e-05	0.000777	CcSEcCtD
Naloxone—Body temperature increased—Oxcarbazepine—epilepsy syndrome	8.85e-05	0.000777	CcSEcCtD
Naloxone—Diarrhoea—Fosphenytoin—epilepsy syndrome	8.85e-05	0.000777	CcSEcCtD
Naloxone—Vomiting—Propofol—epilepsy syndrome	8.82e-05	0.000774	CcSEcCtD
Naloxone—Hypertension—Valproic Acid—epilepsy syndrome	8.73e-05	0.000767	CcSEcCtD
Naloxone—Mediastinal disorder—Gabapentin—epilepsy syndrome	8.68e-05	0.000762	CcSEcCtD
Naloxone—Chills—Gabapentin—epilepsy syndrome	8.64e-05	0.000759	CcSEcCtD
Naloxone—Vomiting—Midazolam—epilepsy syndrome	8.63e-05	0.000758	CcSEcCtD
Naloxone—Diarrhoea—Vigabatrin—epilepsy syndrome	8.63e-05	0.000757	CcSEcCtD
Naloxone—Asthenia—Felbamate—epilepsy syndrome	8.62e-05	0.000757	CcSEcCtD
Naloxone—Methylnaltrexone—CYP2D6—epilepsy syndrome	8.57e-05	0.022	CrCbGaD
Naloxone—Tremor—Pregabalin—epilepsy syndrome	8.57e-05	0.000752	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	8.55e-05	0.000751	CcSEcCtD
Naloxone—Vomiting—Levetiracetam—epilepsy syndrome	8.52e-05	0.000748	CcSEcCtD
Naloxone—Abdominal pain—Carbamazepine—epilepsy syndrome	8.5e-05	0.000746	CcSEcCtD
Naloxone—Body temperature increased—Carbamazepine—epilepsy syndrome	8.5e-05	0.000746	CcSEcCtD
Naloxone—Diarrhoea—Diazepam—epilepsy syndrome	8.5e-05	0.000746	CcSEcCtD
Naloxone—Asthenia—Zonisamide—epilepsy syndrome	8.44e-05	0.000741	CcSEcCtD
Naloxone—Mental disorder—Gabapentin—epilepsy syndrome	8.44e-05	0.000741	CcSEcCtD
Naloxone—Agitation—Pregabalin—epilepsy syndrome	8.4e-05	0.000738	CcSEcCtD
Naloxone—ABCB1—head—epilepsy syndrome	8.33e-05	0.00225	CbGeAlD
Naloxone—Nausea—Propofol—epilepsy syndrome	8.24e-05	0.000723	CcSEcCtD
Naloxone—Tension—Gabapentin—epilepsy syndrome	8.23e-05	0.000722	CcSEcCtD
Naloxone—Vomiting—Fosphenytoin—epilepsy syndrome	8.23e-05	0.000722	CcSEcCtD
Naloxone—Diarrhoea—Felbamate—epilepsy syndrome	8.22e-05	0.000722	CcSEcCtD
Naloxone—Abdominal pain—Lamotrigine—epilepsy syndrome	8.21e-05	0.000721	CcSEcCtD
Naloxone—Body temperature increased—Lamotrigine—epilepsy syndrome	8.21e-05	0.000721	CcSEcCtD
Naloxone—Nervousness—Gabapentin—epilepsy syndrome	8.14e-05	0.000715	CcSEcCtD
Naloxone—Asthenia—Clonazepam—epilepsy syndrome	8.13e-05	0.000714	CcSEcCtD
Naloxone—Nervous system disorder—Valproic Acid—epilepsy syndrome	8.1e-05	0.000711	CcSEcCtD
Naloxone—Asthenia—Phenytoin—epilepsy syndrome	8.08e-05	0.000709	CcSEcCtD
Naloxone—Nausea—Midazolam—epilepsy syndrome	8.06e-05	0.000708	CcSEcCtD
Naloxone—Hallucination—Topiramate—epilepsy syndrome	8.06e-05	0.000708	CcSEcCtD
Naloxone—Buprenorphine—ABCG2—epilepsy syndrome	8.06e-05	0.0207	CrCbGaD
Naloxone—Tachycardia—Valproic Acid—epilepsy syndrome	8.06e-05	0.000707	CcSEcCtD
Naloxone—Diarrhoea—Zonisamide—epilepsy syndrome	8.05e-05	0.000706	CcSEcCtD
Naloxone—Asthenia—Oxcarbazepine—epilepsy syndrome	8.04e-05	0.000705	CcSEcCtD
Naloxone—Vomiting—Vigabatrin—epilepsy syndrome	8.02e-05	0.000704	CcSEcCtD
Naloxone—Skin disorder—Valproic Acid—epilepsy syndrome	8.02e-05	0.000704	CcSEcCtD
Naloxone—Hyperhidrosis—Valproic Acid—epilepsy syndrome	7.98e-05	0.0007	CcSEcCtD
Naloxone—Nausea—Levetiracetam—epilepsy syndrome	7.96e-05	0.000699	CcSEcCtD
Naloxone—Convulsion—Pregabalin—epilepsy syndrome	7.92e-05	0.000695	CcSEcCtD
Naloxone—Hypertension—Pregabalin—epilepsy syndrome	7.89e-05	0.000693	CcSEcCtD
Naloxone—Vomiting—Diazepam—epilepsy syndrome	7.89e-05	0.000693	CcSEcCtD
Naloxone—ABCB1—nervous system—epilepsy syndrome	7.89e-05	0.00213	CbGeAlD
Naloxone—Tremor—Gabapentin—epilepsy syndrome	7.86e-05	0.00069	CcSEcCtD
Naloxone—Diarrhoea—Clonazepam—epilepsy syndrome	7.76e-05	0.000681	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	7.73e-05	0.000679	CcSEcCtD
Naloxone—Asthenia—Carbamazepine—epilepsy syndrome	7.71e-05	0.000677	CcSEcCtD
Naloxone—Agitation—Gabapentin—epilepsy syndrome	7.71e-05	0.000676	CcSEcCtD
Naloxone—Diarrhoea—Phenytoin—epilepsy syndrome	7.7e-05	0.000676	CcSEcCtD
Naloxone—Nausea—Fosphenytoin—epilepsy syndrome	7.69e-05	0.000675	CcSEcCtD
Naloxone—Diarrhoea—Oxcarbazepine—epilepsy syndrome	7.66e-05	0.000673	CcSEcCtD
Naloxone—Vomiting—Felbamate—epilepsy syndrome	7.64e-05	0.000671	CcSEcCtD
Naloxone—ABCB1—central nervous system—epilepsy syndrome	7.6e-05	0.00205	CbGeAlD
Naloxone—Flushing—Topiramate—epilepsy syndrome	7.52e-05	0.00066	CcSEcCtD
Naloxone—Cardiac disorder—Topiramate—epilepsy syndrome	7.52e-05	0.00066	CcSEcCtD
Naloxone—Nausea—Vigabatrin—epilepsy syndrome	7.49e-05	0.000658	CcSEcCtD
Naloxone—Vomiting—Zonisamide—epilepsy syndrome	7.48e-05	0.000656	CcSEcCtD
Naloxone—Asthenia—Lamotrigine—epilepsy syndrome	7.45e-05	0.000654	CcSEcCtD
Naloxone—ABCB1—cerebellum—epilepsy syndrome	7.43e-05	0.002	CbGeAlD
Naloxone—Paraesthesia—Valproic Acid—epilepsy syndrome	7.41e-05	0.000651	CcSEcCtD
Naloxone—Nausea—Diazepam—epilepsy syndrome	7.37e-05	0.000647	CcSEcCtD
Naloxone—Dyspnoea—Valproic Acid—epilepsy syndrome	7.36e-05	0.000646	CcSEcCtD
Naloxone—Diarrhoea—Carbamazepine—epilepsy syndrome	7.35e-05	0.000646	CcSEcCtD
Naloxone—Angiopathy—Topiramate—epilepsy syndrome	7.35e-05	0.000645	CcSEcCtD
Naloxone—Nervous system disorder—Pregabalin—epilepsy syndrome	7.32e-05	0.000642	CcSEcCtD
Naloxone—Mediastinal disorder—Topiramate—epilepsy syndrome	7.3e-05	0.000641	CcSEcCtD
Naloxone—Tachycardia—Pregabalin—epilepsy syndrome	7.28e-05	0.000639	CcSEcCtD
Naloxone—Chills—Topiramate—epilepsy syndrome	7.27e-05	0.000638	CcSEcCtD
Naloxone—Convulsion—Gabapentin—epilepsy syndrome	7.26e-05	0.000638	CcSEcCtD
Naloxone—Skin disorder—Pregabalin—epilepsy syndrome	7.25e-05	0.000636	CcSEcCtD
Naloxone—Hypertension—Gabapentin—epilepsy syndrome	7.24e-05	0.000635	CcSEcCtD
Naloxone—Hyperhidrosis—Pregabalin—epilepsy syndrome	7.21e-05	0.000633	CcSEcCtD
Naloxone—Vomiting—Clonazepam—epilepsy syndrome	7.21e-05	0.000633	CcSEcCtD
Naloxone—Vomiting—Phenytoin—epilepsy syndrome	7.16e-05	0.000628	CcSEcCtD
Naloxone—Nausea—Felbamate—epilepsy syndrome	7.14e-05	0.000627	CcSEcCtD
Naloxone—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	7.13e-05	0.000626	CcSEcCtD
Naloxone—Vomiting—Oxcarbazepine—epilepsy syndrome	7.12e-05	0.000625	CcSEcCtD
Naloxone—Diarrhoea—Lamotrigine—epilepsy syndrome	7.11e-05	0.000624	CcSEcCtD
Naloxone—Mental disorder—Topiramate—epilepsy syndrome	7.1e-05	0.000623	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	7.09e-05	0.000622	CcSEcCtD
Naloxone—Pain—Valproic Acid—epilepsy syndrome	7.06e-05	0.00062	CcSEcCtD
Naloxone—Nausea—Zonisamide—epilepsy syndrome	6.99e-05	0.000613	CcSEcCtD
Naloxone—Tension—Topiramate—epilepsy syndrome	6.92e-05	0.000608	CcSEcCtD
Naloxone—Nervousness—Topiramate—epilepsy syndrome	6.85e-05	0.000601	CcSEcCtD
Naloxone—Vomiting—Carbamazepine—epilepsy syndrome	6.83e-05	0.0006	CcSEcCtD
Naloxone—Nausea—Clonazepam—epilepsy syndrome	6.73e-05	0.000591	CcSEcCtD
Naloxone—Nervous system disorder—Gabapentin—epilepsy syndrome	6.71e-05	0.000589	CcSEcCtD
Naloxone—Paraesthesia—Pregabalin—epilepsy syndrome	6.7e-05	0.000588	CcSEcCtD
Naloxone—Nausea—Phenytoin—epilepsy syndrome	6.69e-05	0.000587	CcSEcCtD
Naloxone—Tachycardia—Gabapentin—epilepsy syndrome	6.68e-05	0.000586	CcSEcCtD
Naloxone—Dyspnoea—Pregabalin—epilepsy syndrome	6.65e-05	0.000584	CcSEcCtD
Naloxone—Nausea—Oxcarbazepine—epilepsy syndrome	6.65e-05	0.000584	CcSEcCtD
Naloxone—Skin disorder—Gabapentin—epilepsy syndrome	6.65e-05	0.000583	CcSEcCtD
Naloxone—Hyperhidrosis—Gabapentin—epilepsy syndrome	6.62e-05	0.000581	CcSEcCtD
Naloxone—Tremor—Topiramate—epilepsy syndrome	6.61e-05	0.00058	CcSEcCtD
Naloxone—Vomiting—Lamotrigine—epilepsy syndrome	6.6e-05	0.00058	CcSEcCtD
Naloxone—Abdominal pain—Valproic Acid—epilepsy syndrome	6.53e-05	0.000573	CcSEcCtD
Naloxone—Body temperature increased—Valproic Acid—epilepsy syndrome	6.53e-05	0.000573	CcSEcCtD
Naloxone—Agitation—Topiramate—epilepsy syndrome	6.48e-05	0.000569	CcSEcCtD
Naloxone—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	6.44e-05	0.000566	CcSEcCtD
Naloxone—Oxymorphone—CYP2D6—epilepsy syndrome	6.39e-05	0.0164	CrCbGaD
Naloxone—Nausea—Carbamazepine—epilepsy syndrome	6.38e-05	0.00056	CcSEcCtD
Naloxone—Pain—Pregabalin—epilepsy syndrome	6.38e-05	0.00056	CcSEcCtD
Naloxone—Buprenorphine—CYP2C19—epilepsy syndrome	6.34e-05	0.0162	CrCbGaD
Naloxone—Nausea—Lamotrigine—epilepsy syndrome	6.17e-05	0.000542	CcSEcCtD
Naloxone—Paraesthesia—Gabapentin—epilepsy syndrome	6.14e-05	0.000539	CcSEcCtD
Naloxone—Convulsion—Topiramate—epilepsy syndrome	6.11e-05	0.000537	CcSEcCtD
Naloxone—Dyspnoea—Gabapentin—epilepsy syndrome	6.1e-05	0.000536	CcSEcCtD
Naloxone—Hypertension—Topiramate—epilepsy syndrome	6.09e-05	0.000535	CcSEcCtD
Naloxone—ABCB1—brain—epilepsy syndrome	6.03e-05	0.00163	CbGeAlD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	5.96e-05	0.000524	CcSEcCtD
Naloxone—Asthenia—Valproic Acid—epilepsy syndrome	5.92e-05	0.00052	CcSEcCtD
Naloxone—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	5.91e-05	0.000519	CcSEcCtD
Naloxone—Body temperature increased—Pregabalin—epilepsy syndrome	5.9e-05	0.000518	CcSEcCtD
Naloxone—Abdominal pain—Pregabalin—epilepsy syndrome	5.9e-05	0.000518	CcSEcCtD
Naloxone—Pain—Gabapentin—epilepsy syndrome	5.85e-05	0.000514	CcSEcCtD
Naloxone—Diarrhoea—Valproic Acid—epilepsy syndrome	5.65e-05	0.000496	CcSEcCtD
Naloxone—Nervous system disorder—Topiramate—epilepsy syndrome	5.65e-05	0.000496	CcSEcCtD
Naloxone—Tachycardia—Topiramate—epilepsy syndrome	5.62e-05	0.000493	CcSEcCtD
Naloxone—Skin disorder—Topiramate—epilepsy syndrome	5.59e-05	0.000491	CcSEcCtD
Naloxone—Hydrocodone—CYP2D6—epilepsy syndrome	5.59e-05	0.0143	CrCbGaD
Naloxone—Hyperhidrosis—Topiramate—epilepsy syndrome	5.57e-05	0.000489	CcSEcCtD
Naloxone—Abdominal pain—Gabapentin—epilepsy syndrome	5.41e-05	0.000475	CcSEcCtD
Naloxone—Body temperature increased—Gabapentin—epilepsy syndrome	5.41e-05	0.000475	CcSEcCtD
Naloxone—Asthenia—Pregabalin—epilepsy syndrome	5.35e-05	0.00047	CcSEcCtD
Naloxone—Vomiting—Valproic Acid—epilepsy syndrome	5.25e-05	0.000461	CcSEcCtD
Naloxone—Paraesthesia—Topiramate—epilepsy syndrome	5.17e-05	0.000454	CcSEcCtD
Naloxone—Dyspnoea—Topiramate—epilepsy syndrome	5.13e-05	0.000451	CcSEcCtD
Naloxone—Diarrhoea—Pregabalin—epilepsy syndrome	5.11e-05	0.000448	CcSEcCtD
Naloxone—Oxycodone—CYP2D6—epilepsy syndrome	5.1e-05	0.0131	CrCbGaD
Naloxone—Gastrointestinal disorder—Topiramate—epilepsy syndrome	4.97e-05	0.000436	CcSEcCtD
Naloxone—Pain—Topiramate—epilepsy syndrome	4.92e-05	0.000432	CcSEcCtD
Naloxone—Asthenia—Gabapentin—epilepsy syndrome	4.91e-05	0.000431	CcSEcCtD
Naloxone—Nausea—Valproic Acid—epilepsy syndrome	4.9e-05	0.00043	CcSEcCtD
Naloxone—Vomiting—Pregabalin—epilepsy syndrome	4.74e-05	0.000417	CcSEcCtD
Naloxone—Buprenorphine—CYP2D6—epilepsy syndrome	4.7e-05	0.012	CrCbGaD
Naloxone—Diarrhoea—Gabapentin—epilepsy syndrome	4.68e-05	0.000411	CcSEcCtD
Naloxone—Hydromorphone—CYP2D6—epilepsy syndrome	4.63e-05	0.0119	CrCbGaD
Naloxone—Naltrexone—ABCB1—epilepsy syndrome	4.57e-05	0.0117	CrCbGaD
Naloxone—Abdominal pain—Topiramate—epilepsy syndrome	4.55e-05	0.0004	CcSEcCtD
Naloxone—Body temperature increased—Topiramate—epilepsy syndrome	4.55e-05	0.0004	CcSEcCtD
Naloxone—Nausea—Pregabalin—epilepsy syndrome	4.43e-05	0.000389	CcSEcCtD
Naloxone—Vomiting—Gabapentin—epilepsy syndrome	4.35e-05	0.000382	CcSEcCtD
Naloxone—Asthenia—Topiramate—epilepsy syndrome	4.13e-05	0.000363	CcSEcCtD
Naloxone—Nausea—Gabapentin—epilepsy syndrome	4.06e-05	0.000357	CcSEcCtD
Naloxone—Diarrhoea—Topiramate—epilepsy syndrome	3.94e-05	0.000346	CcSEcCtD
Naloxone—Morphine—CYP2D6—epilepsy syndrome	3.94e-05	0.0101	CrCbGaD
Naloxone—Vomiting—Topiramate—epilepsy syndrome	3.66e-05	0.000321	CcSEcCtD
Naloxone—Nausea—Topiramate—epilepsy syndrome	3.42e-05	0.0003	CcSEcCtD
Naloxone—Buprenorphine—ABCB1—epilepsy syndrome	3.35e-05	0.0086	CrCbGaD
Naloxone—Morphine—ABCB1—epilepsy syndrome	2.81e-05	0.0072	CrCbGaD
Naloxone—OPRK1—Signaling Pathways—MEF2C—epilepsy syndrome	2.61e-06	2.52e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—JUNB—epilepsy syndrome	2.6e-06	2.52e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CNR1—epilepsy syndrome	2.6e-06	2.52e-05	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	2.6e-06	2.52e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—PLCB1—epilepsy syndrome	2.59e-06	2.51e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—TSC2—epilepsy syndrome	2.58e-06	2.5e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—AGT—epilepsy syndrome	2.57e-06	2.49e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—CHRM3—epilepsy syndrome	2.57e-06	2.49e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	2.57e-06	2.49e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—TSC2—epilepsy syndrome	2.57e-06	2.49e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—AGT—epilepsy syndrome	2.57e-06	2.48e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	2.55e-06	2.47e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—HTR7—epilepsy syndrome	2.54e-06	2.46e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—APOE—epilepsy syndrome	2.52e-06	2.44e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—YWHAZ—epilepsy syndrome	2.52e-06	2.44e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—S100B—epilepsy syndrome	2.52e-06	2.44e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—APOE—epilepsy syndrome	2.51e-06	2.43e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—SOCS3—epilepsy syndrome	2.49e-06	2.41e-05	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—AGT—epilepsy syndrome	2.49e-06	2.41e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—NGF—epilepsy syndrome	2.49e-06	2.41e-05	CbGpPWpGaD
Naloxone—CREB1—Disease—MTOR—epilepsy syndrome	2.49e-06	2.41e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CDC42—epilepsy syndrome	2.49e-06	2.41e-05	CbGpPWpGaD
Naloxone—CREB1—Immune System—IL1B—epilepsy syndrome	2.49e-06	2.41e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—KDR—epilepsy syndrome	2.47e-06	2.39e-05	CbGpPWpGaD
Naloxone—CREB1—Disease—PTGS2—epilepsy syndrome	2.47e-06	2.39e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—HBEGF—epilepsy syndrome	2.46e-06	2.39e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—KDR—epilepsy syndrome	2.46e-06	2.39e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	2.46e-06	2.38e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—GBE1—epilepsy syndrome	2.46e-06	2.38e-05	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—APOE—epilepsy syndrome	2.44e-06	2.36e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—CCR5—epilepsy syndrome	2.42e-06	2.35e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—AKT3—epilepsy syndrome	2.42e-06	2.34e-05	CbGpPWpGaD
Naloxone—CREB1—Immune System—JUN—epilepsy syndrome	2.41e-06	2.33e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—AVP—epilepsy syndrome	2.41e-06	2.33e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—ABCG2—epilepsy syndrome	2.41e-06	2.33e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—ABCG2—epilepsy syndrome	2.39e-06	2.32e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—PRKCB—epilepsy syndrome	2.38e-06	2.3e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—HTR2A—epilepsy syndrome	2.37e-06	2.3e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—PRKCB—epilepsy syndrome	2.37e-06	2.3e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—IL6ST—epilepsy syndrome	2.37e-06	2.29e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—ADAM10—epilepsy syndrome	2.36e-06	2.29e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—IL6ST—epilepsy syndrome	2.36e-06	2.29e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—CYP2C19—epilepsy syndrome	2.35e-06	2.27e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—CYP2C19—epilepsy syndrome	2.33e-06	2.26e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—CYP11A1—epilepsy syndrome	2.33e-06	2.26e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—CYP11A1—epilepsy syndrome	2.32e-06	2.24e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.32e-06	2.24e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	2.31e-06	2.24e-05	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—AKT1—epilepsy syndrome	2.31e-06	2.23e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.3e-06	2.23e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—HES1—epilepsy syndrome	2.28e-06	2.21e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—TSC2—epilepsy syndrome	2.25e-06	2.18e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—AGT—epilepsy syndrome	2.25e-06	2.18e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	2.25e-06	2.18e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—S100B—epilepsy syndrome	2.23e-06	2.16e-05	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—AKT1—epilepsy syndrome	2.22e-06	2.14e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—FYN—epilepsy syndrome	2.22e-06	2.14e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—SOCS3—epilepsy syndrome	2.21e-06	2.14e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—H2AFX—epilepsy syndrome	2.21e-06	2.14e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CDC42—epilepsy syndrome	2.21e-06	2.14e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—APOE—epilepsy syndrome	2.21e-06	2.13e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—MEF2C—epilepsy syndrome	2.2e-06	2.13e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—NT5E—epilepsy syndrome	2.19e-06	2.12e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—ALAD—epilepsy syndrome	2.19e-06	2.12e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—POMC—epilepsy syndrome	2.17e-06	2.1e-05	CbGpPWpGaD
Naloxone—CREB1—Immune System—SRC—epilepsy syndrome	2.16e-06	2.09e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—POMC—epilepsy syndrome	2.16e-06	2.09e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—KDR—epilepsy syndrome	2.16e-06	2.09e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—AVP—epilepsy syndrome	2.14e-06	2.07e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—YWHAZ—epilepsy syndrome	2.13e-06	2.06e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—CCL2—epilepsy syndrome	2.12e-06	2.05e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—CCL2—epilepsy syndrome	2.11e-06	2.05e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.11e-06	2.04e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—NGF—epilepsy syndrome	2.11e-06	2.04e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—CYP2D6—epilepsy syndrome	2.1e-06	2.04e-05	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—POMC—epilepsy syndrome	2.1e-06	2.03e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—ABCG2—epilepsy syndrome	2.1e-06	2.03e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—CYP2D6—epilepsy syndrome	2.09e-06	2.03e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	2.09e-06	2.03e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	2.09e-06	2.03e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—PRKCB—epilepsy syndrome	2.08e-06	2.01e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—IL6ST—epilepsy syndrome	2.07e-06	2.01e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CCR5—epilepsy syndrome	2.05e-06	1.98e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	2.05e-06	1.98e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	2.04e-06	1.98e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	2.03e-06	1.97e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—HES1—epilepsy syndrome	2.02e-06	1.96e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—ADSL—epilepsy syndrome	2.01e-06	1.94e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—HTR2A—epilepsy syndrome	2e-06	1.94e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	2e-06	1.94e-05	CbGpPWpGaD
Naloxone—CREB1—Disease—SRC—epilepsy syndrome	2e-06	1.93e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—BCHE—epilepsy syndrome	1.99e-06	1.93e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—ADRA2A—epilepsy syndrome	1.99e-06	1.93e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—BCHE—epilepsy syndrome	1.98e-06	1.92e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—GLUL—epilepsy syndrome	1.97e-06	1.9e-05	CbGpPWpGaD
Naloxone—ALB—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	1.97e-06	1.9e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—FYN—epilepsy syndrome	1.96e-06	1.9e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—H2AFX—epilepsy syndrome	1.96e-06	1.89e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—MEF2C—epilepsy syndrome	1.95e-06	1.89e-05	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	1.94e-06	1.87e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	1.93e-06	1.87e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—FGF2—epilepsy syndrome	1.92e-06	1.86e-05	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—ALB—epilepsy syndrome	1.91e-06	1.85e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—FGF2—epilepsy syndrome	1.91e-06	1.85e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—TSC2—epilepsy syndrome	1.9e-06	1.84e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	1.9e-06	1.84e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—AGT—epilepsy syndrome	1.9e-06	1.84e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—POMC—epilepsy syndrome	1.89e-06	1.83e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—SLC2A1—epilepsy syndrome	1.89e-06	1.83e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.89e-06	1.83e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	1.88e-06	1.82e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—TH—epilepsy syndrome	1.88e-06	1.82e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—PLCB1—epilepsy syndrome	1.87e-06	1.81e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—NGF—epilepsy syndrome	1.87e-06	1.81e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—TH—epilepsy syndrome	1.87e-06	1.81e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—APOE—epilepsy syndrome	1.86e-06	1.8e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—CCL2—epilepsy syndrome	1.85e-06	1.79e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.85e-06	1.79e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.84e-06	1.78e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	1.83e-06	1.77e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—KDR—epilepsy syndrome	1.83e-06	1.77e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CCR5—epilepsy syndrome	1.82e-06	1.76e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	1.81e-06	1.75e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—RELA—epilepsy syndrome	1.78e-06	1.72e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—HTR2A—epilepsy syndrome	1.78e-06	1.72e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—RELA—epilepsy syndrome	1.77e-06	1.72e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—PRKCB—epilepsy syndrome	1.76e-06	1.7e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—AQP1—epilepsy syndrome	1.75e-06	1.7e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—IL6ST—epilepsy syndrome	1.75e-06	1.69e-05	CbGpPWpGaD
Naloxone—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.75e-06	1.69e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	1.75e-06	1.69e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—MTOR—epilepsy syndrome	1.74e-06	1.69e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—MTOR—epilepsy syndrome	1.74e-06	1.68e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—BCHE—epilepsy syndrome	1.74e-06	1.68e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—TSC2—epilepsy syndrome	1.69e-06	1.63e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—AGT—epilepsy syndrome	1.69e-06	1.63e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—FGF2—epilepsy syndrome	1.68e-06	1.62e-05	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—PTGS2—epilepsy syndrome	1.67e-06	1.62e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	1.66e-06	1.61e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—APOE—epilepsy syndrome	1.65e-06	1.6e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—PLCB1—epilepsy syndrome	1.64e-06	1.59e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—TH—epilepsy syndrome	1.63e-06	1.58e-05	CbGpPWpGaD
Naloxone—ALB—Hemostasis—SRC—epilepsy syndrome	1.63e-06	1.58e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—KDR—epilepsy syndrome	1.62e-06	1.57e-05	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—AKT1—epilepsy syndrome	1.61e-06	1.56e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—CASP3—epilepsy syndrome	1.6e-06	1.55e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—POMC—epilepsy syndrome	1.6e-06	1.55e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—CASP3—epilepsy syndrome	1.6e-06	1.55e-05	CbGpPWpGaD
Naloxone—ALB—Hemostasis—VEGFA—epilepsy syndrome	1.59e-06	1.54e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	1.59e-06	1.53e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	1.59e-06	1.53e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CCL2—epilepsy syndrome	1.57e-06	1.52e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	1.57e-06	1.52e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—JUN—epilepsy syndrome	1.56e-06	1.51e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—PRKCB—epilepsy syndrome	1.56e-06	1.51e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—HMOX1—epilepsy syndrome	1.56e-06	1.51e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—RELA—epilepsy syndrome	1.55e-06	1.51e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—JUN—epilepsy syndrome	1.55e-06	1.5e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—IL6ST—epilepsy syndrome	1.55e-06	1.5e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—CAT—epilepsy syndrome	1.54e-06	1.5e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—CAT—epilepsy syndrome	1.54e-06	1.49e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—MTOR—epilepsy syndrome	1.52e-06	1.48e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—MMP9—epilepsy syndrome	1.52e-06	1.47e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—MMP9—epilepsy syndrome	1.51e-06	1.46e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	1.5e-06	1.45e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—ABCB1—epilepsy syndrome	1.49e-06	1.45e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—AKT1—epilepsy syndrome	1.47e-06	1.42e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—AKT1—epilepsy syndrome	1.47e-06	1.42e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—POMC—epilepsy syndrome	1.42e-06	1.37e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—FGF2—epilepsy syndrome	1.42e-06	1.37e-05	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—AKT1—epilepsy syndrome	1.42e-06	1.37e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—CASP3—epilepsy syndrome	1.4e-06	1.36e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—SRC—epilepsy syndrome	1.4e-06	1.35e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—GPX1—epilepsy syndrome	1.4e-06	1.35e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—SRC—epilepsy syndrome	1.39e-06	1.35e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—GPX1—epilepsy syndrome	1.39e-06	1.34e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CCL2—epilepsy syndrome	1.39e-06	1.34e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—HMOX1—epilepsy syndrome	1.36e-06	1.32e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—JUN—epilepsy syndrome	1.36e-06	1.32e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—VEGFA—epilepsy syndrome	1.36e-06	1.32e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—VEGFA—epilepsy syndrome	1.36e-06	1.31e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—CAT—epilepsy syndrome	1.35e-06	1.3e-05	CbGpPWpGaD
Naloxone—CREB1—Immune System—AKT1—epilepsy syndrome	1.34e-06	1.3e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—MMP9—epilepsy syndrome	1.33e-06	1.28e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—RELA—epilepsy syndrome	1.31e-06	1.27e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.29e-06	1.25e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—MTOR—epilepsy syndrome	1.29e-06	1.25e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—AKT1—epilepsy syndrome	1.29e-06	1.24e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.26e-06	1.22e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—FGF2—epilepsy syndrome	1.26e-06	1.22e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.25e-06	1.21e-05	CbGpPWpGaD
Naloxone—CREB1—Disease—AKT1—epilepsy syndrome	1.24e-06	1.2e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—AGT—epilepsy syndrome	1.22e-06	1.19e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—SRC—epilepsy syndrome	1.22e-06	1.18e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—AGT—epilepsy syndrome	1.22e-06	1.18e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—GPX1—epilepsy syndrome	1.22e-06	1.18e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—APOE—epilepsy syndrome	1.2e-06	1.16e-05	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	1.2e-06	1.16e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—APOE—epilepsy syndrome	1.19e-06	1.16e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—VEGFA—epilepsy syndrome	1.19e-06	1.15e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CASP3—epilepsy syndrome	1.19e-06	1.15e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—RELA—epilepsy syndrome	1.17e-06	1.13e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—JUN—epilepsy syndrome	1.15e-06	1.11e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—MTOR—epilepsy syndrome	1.14e-06	1.11e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.13e-06	1.09e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—MMP9—epilepsy syndrome	1.12e-06	1.08e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—AKT1—epilepsy syndrome	1.09e-06	1.05e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.08e-06	1.04e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.07e-06	1.04e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—AGT—epilepsy syndrome	1.07e-06	1.03e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CASP3—epilepsy syndrome	1.05e-06	1.02e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—APOE—epilepsy syndrome	1.05e-06	1.01e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—SRC—epilepsy syndrome	1.03e-06	1e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—POMC—epilepsy syndrome	1.03e-06	9.98e-06	CbGpPWpGaD
Naloxone—ALB—Metabolism—POMC—epilepsy syndrome	1.03e-06	9.92e-06	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.02e-06	9.89e-06	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—JUN—epilepsy syndrome	1.02e-06	9.88e-06	CbGpPWpGaD
Naloxone—ALB—Hemostasis—AKT1—epilepsy syndrome	1.01e-06	9.81e-06	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.01e-06	9.78e-06	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—TH—epilepsy syndrome	1.01e-06	9.75e-06	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—VEGFA—epilepsy syndrome	1.01e-06	9.74e-06	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—MMP9—epilepsy syndrome	9.93e-07	9.62e-06	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—ALB—epilepsy syndrome	9.4e-07	9.1e-06	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—SRC—epilepsy syndrome	9.16e-07	8.87e-06	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—POMC—epilepsy syndrome	8.98e-07	8.7e-06	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—VEGFA—epilepsy syndrome	8.92e-07	8.63e-06	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—AKT1—epilepsy syndrome	8.75e-07	8.47e-06	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—AKT1—epilepsy syndrome	8.69e-07	8.41e-06	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—AKT1—epilepsy syndrome	8.66e-07	8.38e-06	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—AKT1—epilepsy syndrome	8.41e-07	8.14e-06	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	8.4e-07	8.13e-06	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—CAT—epilepsy syndrome	8.29e-07	8.03e-06	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	8.22e-07	7.96e-06	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—ALB—epilepsy syndrome	8.19e-07	7.93e-06	CbGpPWpGaD
Naloxone—ALB—Metabolism—PTGS2—epilepsy syndrome	8.18e-07	7.92e-06	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	8.07e-07	7.81e-06	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—AKT1—epilepsy syndrome	7.59e-07	7.35e-06	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—GPX1—epilepsy syndrome	7.5e-07	7.26e-06	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—PTGS2—epilepsy syndrome	7.16e-07	6.94e-06	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—AGT—epilepsy syndrome	6.57e-07	6.36e-06	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—APOE—epilepsy syndrome	6.44e-07	6.24e-06	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—AKT1—epilepsy syndrome	6.42e-07	6.21e-06	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—AKT1—epilepsy syndrome	5.69e-07	5.51e-06	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—POMC—epilepsy syndrome	5.53e-07	5.36e-06	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—ALB—epilepsy syndrome	5.05e-07	4.88e-06	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	4.41e-07	4.27e-06	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—AKT1—epilepsy syndrome	4.13e-07	4e-06	CbGpPWpGaD
Naloxone—ALB—Metabolism—AKT1—epilepsy syndrome	4.11e-07	3.98e-06	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—AKT1—epilepsy syndrome	3.6e-07	3.49e-06	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—AKT1—epilepsy syndrome	2.22e-07	2.15e-06	CbGpPWpGaD
